(Q45103735)
Statements
PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers (English)
Albert Lladó
Fernando Castellanos